Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boehringer Ingelheim
Age
20–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Condition: Either of the following criteria is satisfied in laboratory tests:
* Presence of a renal parenchymal disorder such as chronic glomerulonephritis is confirmed (serum creatinine \< 3.0 mg/dL)
* Presence of a renal function disorder (serum creatinine ≥ 1.5 mg/dL to \< 3.0 mg/dL)
Age: ≥ 20 years
Sex: Either male or female
Patient status: Either outpatients or inpatients. However, the patient status should remain unchanged throughout the study period
Blood pressure (BP):
* \[Outpatients\] The last 2 measurements of sitting BP out of at least 3 taken during the observation period (2 - 4 weeks) should be stable and a mean of the two measurements should be ≥160 mmHg for systolic BP (SBP) and ≥95 mmHg for diastolic BP (DBP)
* \[Inpatients\] The last 2 measurements of supine BP taken during the observation period (1 week) should be stable and a mean of the 2 measurements should be ≥ 150 mmHg for SBP and ≥ 90 mmHg for DBP
You may not be if
Renovascular hypertension
Undergoing haemodialysis
Severe hypertension (Diastolic BP ≥ 120 mmHg)
Severe heart failure, angina pectoris, or history of myocardial infarction
Atrioventricular conduction disturbance (degree II to III), atrial fibrillation, or serious arrhythmia
Symptoms of cerebrovascular disorder
Serious hepatic dysfunction
Uncontrolled diabetes
Peptic ulcer
History of hypersensitivity to drugs
Hyperkalaemia
Undergoing treatment with a digitalis preparation
Pregnant, breast feeding, possibly pregnant or planning to become pregnant during this study
Otherwise judged ineligible by the investigator
Clareo Health | BIBR 277 Capsules in Hypertensive Patients With Nephropathy
